H.C. Wainwright on Biomea Fusion Inc. (BMEA) amid 17% Gain: 'Another step toward confirmatory Phase 2 data and T2D development strategy'

August 24, 2026 9:43 AM

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $4.00 price target on Biomea Fusion Inc. (NASDAQ: BMEA).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found